LAUSR

Changing TACTICS in intermediate HCC: TACE plus sorafenib

Sign Up to like & get
recommendations!
1 Published in 2020 at "Gut"

DOI: 10.1136/gutjnl-2020-320692

Abstract: Hepatocellular carcinoma (HCC) represents a serious health problem, mainly due to the high cancer-related mortality. Transarterial chemoembolisation (TACE) is currently used as the first-line treatment for intermediate-stage HCC (Barcelona Clinic Liver Cancer (BCLC) stage B),… read more here.

Keywords: tace; plus sorafenib; tace plus; bclc stage ... See more keywords